SOLID BIOSCIENCES INC (SLDB)

US83422E2046 - Common Stock

4.03  +0.11 (+2.81%)

After market: 4.01 -0.02 (-0.5%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
13.62M8.09M
-40.60%
897.6K
-100.00%
278.185K
-100.00%
15.436M121.81M
689.13%
285.34M
134.25%
480.77M
68.49%
689.17M
43.35%
EBITDA
YoY % growth
-82.55M
29.14%
-69.29M
16.06%
-92M
-32.78%
-104.04M
-10.58%
-125.46M
-23.32%
-138.72M
-10.57%
-146.88M
-5.88%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-86.47M
27.53%
-72.25M
16.45%
-94.41M
-30.67%
-107.298M
-10.49%
-126.332M
-21.11%
-146.639M
-16.07%
-169.458M
-15.56%
-188.546M
-11.26%
-108.615M
42.39%
11.713M
110.78%
166.37M
1,320.39%
333.42M
100.41%
Operating Margin
N/A-530.47%-1,167.00%-11,953.86%N/A-52,712.76%N/A-1,221.47%-89.17%4.10%34.60%48.38%
EPS
YoY % growth
-24.75
43.69%
-10.20
58.79%
-12.13
-18.92%
-4.82
60.43%
-3.00
37.45%
-2.96
1.48%
-3.04
-2.71%
-2.33
23.29%
-1.14
51.20%
0.07
105.83%
1.95
2,846.15%
4.08
108.88%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.81
18.60%
-0.74
-16.03%
-0.76
-24.41%
-0.77
3.16%
-0.78
4.76%
-0.73
1.79%
-0.76
-0.13%
-0.79
-2.67%
-0.83
-7.24%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
-36.72M
-86.55%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-35.29M
-58.50%
-33.099M
-41.74%
-33.915M
-20.21%
-34.731M
-18.23%
-35.649M
-1.02%
-46.206M
-39.60%
-50.592M
-49.17%
-54.978M
-58.30%
-59.466M
-66.81%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.79
24.76%
-0.68-0.11-16.02%
Q2 2024
Q2Q % growth
-0.61
51.20%
-0.680.079.90%
Q1 2024
Q2Q % growth
-0.64
57.33%
-0.650.011.90%
Q4 2023
Q2Q % growth
-1.00
64.54%
-1.010.010.77%
Q3 2023
Q2Q % growth
-1.05
61.25%
-1.210.1613.35%
Q2 2023
Q2Q % growth
-1.25
62.12%
-1.570.3220.16%
Q1 2023
Q2Q % growth
-1.50
54.55%
-2.090.5928.35%
Q4 2022
Q2Q % growth
-2.82
-17.50%
-1.69-1.13-67.30%
Q3 2022
Q2Q % growth
-2.71
-12.92%
-2.720.010.49%
Q2 2022
Q2Q % growth
-3.30
-29.41%
-3.21-0.09-2.71%
Q1 2022
Q2Q % growth
-3.30
-15.79%
-2.82-0.48-17.22%
Q4 2021
Q2Q % growth
-2.40
48.39%
-2.970.5719.14%
Q3 2021
Q2Q % growth
-2.40
63.64%
-3.080.6822.13%
Q2 2021
Q2Q % growth
-2.55
56.41%
-2.880.3311.50%
Q1 2021
Q2Q % growth
-2.85
62.75%
-4.962.1142.51%
Q4 2020
Q2Q % growth
-4.65
52.31%
-5.190.5410.40%
Q3 2020
Q2Q % growth
-6.60
34.33%
-5.28-1.32-25.04%
Q2 2020
Q2Q % growth
-5.85
48.68%
-7.601.7523.04%
Q1 2020
Q2Q % growth
-7.65
40.00%
-7.990.344.21%
Q4 2019
Q2Q % growth
-9.75 -9.32-0.43-4.58%
Q3 2019
Q2Q % growth
-10.05 -9.84-0.21-2.09%
Q2 2019
Q2Q % growth
-11.40 -12.040.645.35%
Q1 2019
Q2Q % growth
-12.75 -9.67-3.08-31.79%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth
1.056M-1.056M-100.00%
Q4 2023
Q2Q % growth
1.122M-1.122M-100.00%
Q3 2023
Q2Q % growth
1.122M-1.122M-100.00%
Q2 2023
Q2Q % growth

-100.00%
1.496M-1.496M-100.00%
Q1 2023
Q2Q % growth

-100.00%
1.496M-1.496M-100.00%
Q4 2022
Q2Q % growth

-100.00%
%
Q3 2022
Q2Q % growth

-100.00%
1.199M-1.199M-100.00%
Q2 2022
Q2Q % growth
6.17M
71.87%
2.576M3.594M139.52%
Q1 2022
Q2Q % growth
1.93M
-42.22%
2.732M-802K-29.36%
Q4 2021
Q2Q % growth
3.15M 2.128M1.022M48.03%
Q3 2021
Q2Q % growth
3.54M 1.122M2.418M215.51%
Q2 2021
Q2Q % growth
3.59M 1.285M2.305M179.38%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% -3.33% -12.64%
Revenue0% 0% N/A N/A